However, there was no statistically significant difference in CDKN1B expression between the cancer tissues from diffuse large B-cell lymphoma (DLBC), acute myeloid leukemia (AML), SKCM, and testicular germ cell tumors (TGCT), all of which are lymphoid neoplasms (Fig. 1B). This evidence concerns the gene CDKN1B and cancer.